Nirmatrelvir/ritonavir
id:
nirmatrelvir-ritonavir-186-1809277
title:
Nirmatrelvir/ritonavir
text:
Nirmatrelvir/ritonavir, sold under the brand name Paxlovid, is a co-packaged medication used as a treatment for COVID‑19. It contains the antiviral medications nirmatrelvir and ritonavir and was developed by Pfizer. Nirmatrelvir inhibits SARS-CoV-2 main protease, while ritonavir is a strong CYP3A inhibitor, slowing down nirmatrelvir metabolism and therefore boosting its effect. It is taken by mouth. In unvaccinated high-risk people with COVID‑19, nirmatrelvir/ritonavir can reduce the risk of hos
brand slug:
wiki
category slug:
encyclopedia
description:
Antiviral combination medication
original url:
https://en.wikipedia.org/wiki/Nirmatrelvir/ritonavir
date created:
2021-12-18T05:57:47Z
date modified:
2024-09-08T10:06:47Z
main entity:
{"identifier":"Q110442458","url":"https://www.wikidata.org/entity/Q110442458"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/6/63/PF-07321332.svg","width":512,"height":290}
fields total:
13
integrity:
16